Most Active Stories
- Mid-Continent Chairman Confirms Layoffs, School Will Operate Through June 30
- MSU Transfer Credit Could Be Available for Mid-Continent Students; AG Conway Pledges Support
- Murray High School Assistant Charged with Rape
- Mid-Continent University Appoints Tom Walden as New Acting President
- Ky. Road Plan Includes $368M for Jackson Purchase
Mon November 18, 2013
Experimental Treatment Offers Hope To Parkinson's Patients
A team of doctors at the University of Kentucky will investigate new treatments for patients with Parkinson’s disease. It potentially could reverse the brain damage done by Parkinson’s.
The current clinical trial focuses on transplanting a nerve taken from a patient’s ankle and implanting it in the brain. So far, five patients have undergone the procedure.
Principal investigator Craig van Horne said the newly grafted nerves are also stimulated by electrodes. Over time, Van Horne said, the hope is the brain will heal.
“If we have substantial improvements at a year, that would be something that’s really worth looking into further. Even if we don’t reverse it, but if we can just halt the progression, I think we would be better off than we are now,” said van Horne.
Parkinson’s is one of the most common neurological disorders, affecting at least 10,000 Kentuckians. It’s a progressive and degenerative disease causing tremors, rigidity, slow movement, and speech impairment. There is no known cure for Parkinson’s.
Lexington patient Rodney Parsons underwent the deep brain stimulation procedure last spring. Even without the nerve grafting, it made quite a difference.
“I was walking way bent over like this, stood straight up immediately, and turned it on and that’s been it,” said Parsons.
Doctor Greg Gerhardt, who directs the Morris K-Udall Parkinson’s Disease Research Center, said the ailment is quite common in rural areas likeAppalachia.
“Environmental effects on individuals such as toxins and or metals, heavy metals, well water seem to increase the incidence of Parkinson’s disease,” explained Gerhardt.
Still, Gerhardt said the disease’s cause remains a total mystery. Researchers say it may take about a year to determine how well this nerve therapy works.